Fresenius Medical Care AG
corporate_fare Company Profile
Fresenius Medical Care AG (NYSE:FMS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 19 items for FMS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 7/10. Across its 19 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for FMS spans SCHEDULE 13D/A, 6-K, 20-F.
Recent high-impact activity:
- Fresenius SE Sells 13.4M FMC Shares at EUR 39.00, Cutting Stake to 20.9%
- Fresenius Medical Care Q3 Operating Income Down 19%, FY2026 Outlook Narrowed
- Fresenius Medical Care Names Shervin Korangy as New CEO
- FDA Warning Letter Hits Fresenius Kabi's Illinois Facility
- Fresenius Medical Care to Exit China PD Business, Book €110M Q3 Charge
Financial Snapshot
Short Interest & Short Volume
2.21 days to coverFINRA reported short interest of 3,008,522 shares in FMS as of the October 30, 2026 settlement, a 24.0% decrease from the prior period — about 2.2 days to cover at its recent average daily volume. On November 20, 2026, 50.2% of FMS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
FMS files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.